Cidara Therapeutics (CDTX)
NASDAQ:CDTX
Holding CDTX?
Track your performance easily

Cidara Therapeutics (CDTX) Stock Investors

719 Followers
Based on 766,063 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold CDTX
On average, investors allocate 4.04% of their portfolios to CDTX
The average holding size of this company in investors' portfolios.

Investor Sentiment

Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 766,063 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding CDTX

0.2%
Last 7
Days
1.7%
Last 30
Days
Percentages indicate the change in the number of portfolios holding CDTX, out of 766,063 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

CDTX Investor Activity

Action
Any
Any
Investor Performance
Any
Any
No data currently available
Based on the activity of 14,653 investors who made their portfolios public
The table shows changes in CDTX in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

CDTX Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Viking Therapeutics
4.93%
+0.69%
+5.26%
7.63B
Healthcare
Plug Power
5.22%
>-0.01%
+0.14%
1.81B
Industrials
DraftKings
5.44%
+1.26%
-0.14%
35.26B
Consumer Cyclical
Enphase Energy
4.60%
-0.58%
+3.62%
9.04B
Technology
XPeng, Inc. ADR
5.57%
-0.86%
-1.05%
13.95B
Consumer Cyclical
Carnival
6.49%
+1.32%
+8.73%
30.17B
Consumer Cyclical
Abbott Laboratories
3.57%
+0.46%
+13.29%
202.22B
Healthcare
Citigroup
4.76%
+1.74%
+3.76%
129.80B
Financial
Bristol-Myers Squibb
3.48%
-0.30%
-2.11%
109.81B
Healthcare
Li Auto
5.58%
-1.26%
-3.68%
24.53B
Consumer Cyclical
Based on the activity of 766,063 active portfolios
Open your Smart Portfolio

CDTX Investor Analysis

CDTX investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
8.3%
of CDTX holders
are under 35
Average Segment Performance
Average P/E Ratio26.57
Beta9.43
Dividend Yield51.54%
CDTX investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
50.9%
of CDTX holders
are between 35–55
Average Segment Performance
Average P/E Ratio24.84
Beta18.28
Dividend Yield25.17%
CDTX investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
40.7%
of CDTX holders
are over 55
Average Segment Performance
Average P/E Ratio23.97
Beta8.44
Dividend Yield41.02%
Overview of age group and performance of CDTX stock investors
See who invests in CDTX according to age group and performance.

FAQ

How many retail Investors hold CDTX?
<0.1% of TipRanks' retail investors hold CDTX in their portfolios.
    What is CDTX Investor Sentiment?
    CDTX’s Investor Sentiment is Negative.
      What percentage of retail investors changed their holding of CDTX in the last 7 days?
      ▲ 0.2% of TipRanks' retail investors changed their holding of CDTX in the last 7 days.
        What percentage of retail investors changed their holding of CDTX in the last 30 days?
        ▼ 1.7% of TipRanks' retail investors changed their holding of CDTX in the last 30 days.
          What is the average age of retail investors who hold CDTX?
          The average age of CDTX Holders is between 35–55.
            What other stocks have CDTX investors also bought?
            CDTX Investors also bought VKTX, PLUG, DKNG, ENPH, XPEV, CCL, ABT, C, BMY, LI.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ABTAbbott Laboratories
              AAgilent
              BDXBecton Dickinson
              BMRNBioMarin Pharmaceutical
              CPRXCatalyst Pharma
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis